Skip to content

The adjuntive usage of EMD FL in the non-surgical therapy of initial peri-implantitis performed with different decontamination tips

The adjuntive usage of EMD FL in the non-surgical therapy of initial peri-implantitis performed with different decontamination tips : A randomized clinical and biochemical study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250513007
Enrollment
68
Registered
2025-05-13
Start date
2025-01-06
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implant pocket depth 5-7mm with bleeding Radiographically detectable bone loss Cemented &amp

Interventions

After local anesthesia (Ultracain-DS forte, Sanofi, Frankfurt, Germany), the implant surfaces will be treated with Ti curettes (IMPM 1/2T, 11/12T, 13/14T, Hu-Friedy, Chicago, USA),After local anesthes
Conventional titanium curette ,Conventional titanium curette + EMD FL,Oscilitating Chitosan Brush (OCB),Oscilitating Chitosan Brush (OCB) + EMD FL

Sponsors

Straumann
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Peri-implant pocket depth 5-7mm with bleeding Radiographically detectable bone loss Cemented & screw-retained single-unit fixed prosthesis

Exclusion criteria

Exclusion criteria: smoking systemic diseases antibiotic usage the previous 3 months pregnancy and breastfeeding implants with less than 2 mm keratinized mucosa restorative problems and difficulty in accessibility for cleaning

Design outcomes

Primary

MeasureTime frame
Probing pocket depth reduction; measured as a distance between the gingival margin and base of a peri-implant pocket Baseline and 3, 9 month follow-ups mm/ with University of North Carolina periodontal probe

Secondary

MeasureTime frame
Bleeding on probing reduction Baseline and 3, 9 month follow-ups %, assessed simultaneously to the probing measurements, the presence or absence of bleeding up to 30 s after probing and scored as positive (+) or negative (-) bleeding for each point

Countries

Turkey

Contacts

Public ContactGizem Ince Kuka

University of Health Sciences, Hamidiye Dental Faculty

gizem.incekuka@sbu.edu.tr00905308243499

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026